Company intelligence / Profile preview

Sabartech

Paterna (Valencia), Valencian Community, Spain

Ownership: Private
Development stage: Other

Overview

Sabartech develops precision medicine technologies and multi-omics, bioinformatics and ICT-based tools for early detection and risk prediction of age-related syndromes such as sarcopenia and frailty, and collaborates on projects to improve quality of life in lung cancer patients.[1][2][3][4][7]

Therapeutic areas: OncologyNeurologyOtherMetabolic Disorders
Modalities: Non-pharmacological therapyDevice
Industry: Molecular Diagnostics

Partnerships

Institute of Integrative Systems Biology (I2SysBio, University of Valencia)FISABIO (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana)Autonomous University of Madrid (UAM)CIBERESP (Consortium for Biomedical Research in Epidemiology and Public Health)Dawako MedtechSpanish Lung Cancer Patients association (patient collaboration agreement)

Beyond the preview

Go deeper on Sabartech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sabartech.

Explore the full profile